Necrotising fasciitis as atypical presentation of infection with emerging Neisseria meningitidis serogroup W (MenW) clonal complex 11, the Netherlands, March 2017

Euro Surveill. 2017 Jun 8;22(23):30549. doi: 10.2807/1560-7917.ES.2017.22.23.30549.

Abstract

In March 2017, a patient with necrotising fasciitis caused by Neisseria meningitidis serogroup W (MenW) clonal complex 11 was diagnosed in the Netherlands. Unusual and severe presentations of MenW infections are common in the current European epidemic. In the Netherlands, the incidence of MenW infections increased 10-fold, from an average of 0.03 per 100,000 population in 2002-2014 to 0.29 in 2016. Awareness of atypical presentations enables timely adequate treatment and public health action.

Keywords: Emerging or re-emerging diseases; Neisseria meningitidis; meningococcal disease; necrotising fasciitis.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Clindamycin / therapeutic use
  • Debridement
  • Fasciitis, Necrotizing / diagnosis*
  • Fasciitis, Necrotizing / therapy
  • Fever / etiology
  • Humans
  • Meningitis, Meningococcal / diagnosis*
  • Meningitis, Meningococcal / drug therapy
  • Meningitis, Meningococcal / microbiology
  • Meningococcal Infections / diagnosis*
  • Meningococcal Infections / drug therapy
  • Meningococcal Infections / microbiology
  • Neisseria meningitidis, Serogroup W-135 / isolation & purification*
  • Penicillin G / therapeutic use
  • Sepsis / drug therapy
  • Sepsis / microbiology
  • Serogroup
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Clindamycin
  • Penicillin G